Mesa Labs, founded in 1982 and headquartered in the United States, operates within the manufacturing sector, specifically focusing on test and measurement equipment, medical devices, and related corporate services. The company employs between 501 and 1,000 individuals and reported revenue of approximately $245 million. Mesa Labs specializes in sterilization validation for the pharmaceutical, medical device, and in vitro diagnostics industries, where adherence to stringent regulatory standards is critical for ensuring patient safety. A key product offering is the Process Challenge Device (PCD), which is essential for validating sterilization processes. The PCDs are designed to provide a defined resistance to sterilization, helping manufacturers and contract sterilizers confirm the effectiveness of their sterilization cycles. The company emphasizes the importance of using standardized PCDs over homemade alternatives, as the latter can introduce variability and increase the risk of errors, ultimately compromising sterility assurance. Mesa Labs’ expertise in sterilization validation underscores its commitment to supporting the healthcare sector in maintaining compliance and safety standards.